((1aR,7aS,10aS,10bS,E)-1a-Methyl-8-methylene-9-oxo-1a,2,3,6,7,7a,8,9,10a,10b-decahydrooxireno[2',3':9,10]cyclodeca[1,2-b]furan-5-yl)methyl 4-(4-(2-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl)piperazin-1-yl)-4-oxobutanoate

ID: ALA4472461

PubChem CID: 155535536

Max Phase: Preclinical

Molecular Formula: C29H35FN4O9

Molecular Weight: 602.62

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1C(=O)O[C@H]2[C@H]1CC/C(COC(=O)CCC(=O)N1CCN(C(=O)Cn3cc(F)c(=O)[nH]c3=O)CC1)=C\CC[C@@]1(C)O[C@@H]21

Standard InChI:  InChI=1S/C29H35FN4O9/c1-17-19-6-5-18(4-3-9-29(2)25(43-29)24(19)42-27(17)39)16-41-23(37)8-7-21(35)32-10-12-33(13-11-32)22(36)15-34-14-20(30)26(38)31-28(34)40/h4,14,19,24-25H,1,3,5-13,15-16H2,2H3,(H,31,38,40)/b18-4+/t19-,24-,25-,29+/m0/s1

Standard InChI Key:  OFIFYYMGHYMFLA-DNAUFTMUSA-N

Molfile:  

 
     RDKit          2D

 46 50  0  0  0  0  0  0  0  0999 V2000
   28.2474  -15.0352    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.6901  -14.3483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8725  -14.3074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5240  -16.3354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1449  -15.7998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8227  -15.9103    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0101  -15.1120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8233  -15.0425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0085  -14.2476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3126  -13.8216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2758  -12.9957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4859  -13.4895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6070  -12.5106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8117  -12.7330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9953  -12.6083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6906  -13.0377    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.4101  -12.6503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1054  -13.0798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4344  -11.8335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.1995  -14.7745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6084  -13.5315    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   30.9409  -15.9850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6328  -14.9626    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   29.5921  -17.1498    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.3322  -15.4933    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   32.8249  -12.6924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5201  -13.1218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4959  -13.9386    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.2397  -12.7344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9335  -13.1678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6508  -12.7838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6793  -11.9667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9842  -11.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2607  -11.9206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4003  -11.5821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0939  -12.0141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8149  -11.6294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4276  -10.7653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.5049  -12.0665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2236  -11.6852    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.2552  -10.8683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5618  -10.4341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8368  -10.8168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4734  -12.8831    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.9776  -10.4863    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.5919   -9.6174    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  1  0
  5  8  1  0
  7  6  1  0
  6  4  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2  7  1  0
 10 11  1  0
  3 12  1  0
 11 13  2  0
 12 14  1  0
 13 14  1  0
 11 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
  3 20  1  1
  2 21  1  1
  5 22  2  0
  8 23  1  6
  4 24  2  0
  7 25  1  1
 18 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 29 34  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 32 35  1  0
 35 36  1  0
 36 37  1  0
 35 38  2  0
 37 39  1  0
 37 43  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  2  0
 39 44  2  0
 41 45  2  0
 42 46  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4472461

    ---

Associated Targets(Human)

Bel7402/5-FU (373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bel-7402 (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 602.62Molecular Weight (Monoisotopic): 602.2388AlogP: 0.43#Rotatable Bonds: 7
Polar Surface Area: 160.61Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.12CX Basic pKa: CX LogP: 0.04CX LogD: -0.03
Aromatic Rings: 1Heavy Atoms: 43QED Weighted: 0.20Np Likeness Score: 0.79

References

1. Ding Y, Li S, Ge W, Liu Z, Zhang X, Wang M, Chen T, Chen Y, Zhang Q..  (2019)  Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.,  183  [PMID:31553932] [10.1016/j.ejmech.2019.111706]

Source